nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—UGT1A9—Irinotecan—lung cancer	0.321	1	CbGbCtD
Entacapone—COMT—Metapathway biotransformation—GSTA3—lung cancer	0.00125	0.0058	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.00121	0.0056	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—NQO1—lung cancer	0.00119	0.00554	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTA4—lung cancer	0.00119	0.0055	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUNB—lung cancer	0.00118	0.0055	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—APOA1—lung cancer	0.00117	0.00545	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTA4—lung cancer	0.00116	0.00538	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTA2—lung cancer	0.00116	0.00536	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTA4—lung cancer	0.00114	0.0053	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—PRDX1—lung cancer	0.00114	0.0053	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GRIK3—lung cancer	0.00113	0.00527	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTA2—lung cancer	0.00113	0.00524	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.00112	0.00521	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTA1—lung cancer	0.00111	0.00518	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTA1—lung cancer	0.00109	0.00505	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTM2—lung cancer	0.00107	0.00498	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—UGT1A1—lung cancer	0.00104	0.00481	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—AKR1C1—lung cancer	0.00103	0.00477	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—UGT1A1—lung cancer	0.00101	0.0047	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—UGT1A1—lung cancer	0.000998	0.00463	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTP1—lung cancer	0.000989	0.00459	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTM2—lung cancer	0.000941	0.00437	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CNDP2—lung cancer	0.000941	0.00437	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTM2—lung cancer	0.000928	0.00431	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CHRNB4—lung cancer	0.000925	0.00429	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—lung cancer	0.00092	0.00427	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000915	0.00425	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTM1—lung cancer	0.000909	0.00422	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—HPGDS—lung cancer	0.000881	0.00409	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CYP1A1—lung cancer	0.000867	0.00403	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GNG11—lung cancer	0.000865	0.00402	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTA3—lung cancer	0.000865	0.00401	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—HPGDS—lung cancer	0.00086	0.004	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CHRNA5—lung cancer	0.00086	0.00399	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTT1—lung cancer	0.000855	0.00397	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP2A7—lung cancer	0.000851	0.00395	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GCLC—lung cancer	0.000845	0.00392	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP2A7—lung cancer	0.000839	0.0039	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTT1—lung cancer	0.000835	0.00387	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP2A6—lung cancer	0.000825	0.00383	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GCLC—lung cancer	0.000825	0.00383	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—KEAP1—lung cancer	0.000813	0.00377	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTA4—lung cancer	0.000791	0.00367	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000778	0.00361	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—NCOA3—lung cancer	0.000773	0.00359	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTA2—lung cancer	0.000771	0.00358	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTA3—lung cancer	0.000758	0.00352	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOA3—lung cancer	0.000756	0.00351	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTA3—lung cancer	0.000748	0.00347	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTA1—lung cancer	0.000743	0.00345	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—CCND1—lung cancer	0.000735	0.00341	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—ABCC3—lung cancer	0.000735	0.00341	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP2E1—lung cancer	0.000701	0.00326	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CHRNA3—lung cancer	0.000701	0.00325	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTA4—lung cancer	0.000694	0.00322	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP2E1—lung cancer	0.000692	0.00321	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—UGT1A1—lung cancer	0.000691	0.00321	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTA4—lung cancer	0.000684	0.00318	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTA2—lung cancer	0.000676	0.00314	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GNG11—lung cancer	0.000663	0.00308	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—NFE2L2—lung cancer	0.000655	0.00304	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTA1—lung cancer	0.000652	0.00303	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—TGFA—lung cancer	0.000625	0.0029	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—AKR1C1—lung cancer	0.000616	0.00286	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—UGT1A1—lung cancer	0.000606	0.00281	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—UGT1A1—lung cancer	0.000598	0.00278	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000596	0.00277	CbGpPWpGaD
Entacapone—COMT—Neuronal System—ADCY1—lung cancer	0.000596	0.00277	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTP1—lung cancer	0.000592	0.00275	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—MYC—lung cancer	0.00059	0.00274	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTP1—lung cancer	0.000578	0.00269	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTP1—lung cancer	0.000571	0.00265	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GCLC—lung cancer	0.000563	0.00262	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—CYP2A6—lung cancer	0.000563	0.00262	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTM1—lung cancer	0.000544	0.00253	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTM1—lung cancer	0.000532	0.00247	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTM1—lung cancer	0.000524	0.00243	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA3—lung cancer	0.000521	0.00242	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—HPGDS—lung cancer	0.000515	0.00239	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP1A1—lung cancer	0.000504	0.00234	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTT1—lung cancer	0.0005	0.00232	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP1A1—lung cancer	0.000497	0.00231	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GCLC—lung cancer	0.000494	0.00229	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP2A6—lung cancer	0.000494	0.00229	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—lung cancer	0.000478	0.00222	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—NQO1—lung cancer	0.000474	0.0022	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—lung cancer	0.000465	0.00216	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000452	0.0021	CbGpPWpGaD
Entacapone—COMT—Metabolism—COL4A3BP—lung cancer	0.000443	0.00206	CbGpPWpGaD
Entacapone—COMT—Metabolism—AZIN2—lung cancer	0.000443	0.00206	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—CYP1A1—lung cancer	0.000432	0.002	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—lung cancer	0.000429	0.00199	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—lung cancer	0.000422	0.00196	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP2E1—lung cancer	0.00042	0.00195	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	0.000417	0.00194	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP2E1—lung cancer	0.000414	0.00192	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTP1—lung cancer	0.000395	0.00183	CbGpPWpGaD
Entacapone—COMT—Metabolism—ATP5H—lung cancer	0.000377	0.00175	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—POMC—lung cancer	0.000376	0.00174	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—APOA1—lung cancer	0.00037	0.00172	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	0.000366	0.0017	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTM1—lung cancer	0.000363	0.00169	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—lung cancer	0.000362	0.00168	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000351	0.00163	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTP1—lung cancer	0.000347	0.00161	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTP1—lung cancer	0.000342	0.00159	CbGpPWpGaD
Entacapone—COMT—Metabolism—PLBD1—lung cancer	0.000336	0.00156	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—BRAF—lung cancer	0.000329	0.00153	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTM1—lung cancer	0.000318	0.00148	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTM1—lung cancer	0.000314	0.00146	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—CREBBP—lung cancer	0.000313	0.00146	CbGpPWpGaD
Entacapone—COMT—Metabolism—HSD17B10—lung cancer	0.000307	0.00143	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—lung cancer	0.000307	0.00142	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP1A1—lung cancer	0.000302	0.0014	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP1A1—lung cancer	0.000298	0.00138	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—lung cancer	0.000291	0.00135	CbGpPWpGaD
Entacapone—COMT—Metabolism—CKB—lung cancer	0.000286	0.00133	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—MDM2—lung cancer	0.000276	0.00128	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—RAF1—lung cancer	0.000275	0.00127	CbGpPWpGaD
Entacapone—COMT—Metabolism—CNDP2—lung cancer	0.000269	0.00125	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTM2—lung cancer	0.000269	0.00125	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—COL4A3BP—lung cancer	0.000266	0.00123	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AZIN2—lung cancer	0.000266	0.00123	CbGpPWpGaD
Entacapone—COMT—Metabolism—MTMR3—lung cancer	0.000261	0.00121	CbGpPWpGaD
Entacapone—COMT—Metabolism—PGAM1—lung cancer	0.000255	0.00118	CbGpPWpGaD
Entacapone—COMT—Neuronal System—BRAF—lung cancer	0.000252	0.00117	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—lung cancer	0.00025	0.00116	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000248	0.00115	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP2A7—lung cancer	0.000243	0.00113	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.00024	0.00111	CbGpPWpGaD
Entacapone—COMT—Metabolism—SDC4—lung cancer	0.000238	0.0011	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ATP5H—lung cancer	0.000226	0.00105	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—POMC—lung cancer	0.000225	0.00105	CbGpPWpGaD
Entacapone—COMT—Metabolism—RRM1—lung cancer	0.000216	0.00101	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTA3—lung cancer	0.000216	0.00101	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—EP300—lung cancer	0.000214	0.000991	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—lung cancer	0.000211	0.000982	CbGpPWpGaD
Entacapone—COMT—Neuronal System—MDM2—lung cancer	0.000211	0.00098	CbGpPWpGaD
Entacapone—COMT—Neuronal System—RAF1—lung cancer	0.00021	0.000977	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—lung cancer	0.000209	0.00097	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000207	0.000963	CbGpPWpGaD
Entacapone—COMT—Metabolism—B4GALT5—lung cancer	0.000204	0.000945	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLBD1—lung cancer	0.000201	0.000934	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTA4—lung cancer	0.000198	0.000919	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000198	0.000919	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTA2—lung cancer	0.000193	0.000896	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTA1—lung cancer	0.000186	0.000864	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HSD17B10—lung cancer	0.000184	0.000855	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCC3—lung cancer	0.000184	0.000855	CbGpPWpGaD
Entacapone—COMT—Metabolism—AKR1C1—lung cancer	0.000178	0.000828	CbGpPWpGaD
Entacapone—Myalgia—Docetaxel—lung cancer	0.000174	0.000376	CcSEcCtD
Entacapone—Nausea—Vinorelbine—lung cancer	0.000174	0.000375	CcSEcCtD
Entacapone—Gastrointestinal disorder—Etoposide—lung cancer	0.000174	0.000374	CcSEcCtD
Entacapone—Dyspepsia—Paclitaxel—lung cancer	0.000174	0.000374	CcSEcCtD
Entacapone—Body temperature increased—Cisplatin—lung cancer	0.000174	0.000374	CcSEcCtD
Entacapone—Asthenia—Irinotecan—lung cancer	0.000174	0.000374	CcSEcCtD
Entacapone—Fatigue—Etoposide—lung cancer	0.000173	0.000374	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000173	0.000373	CcSEcCtD
Entacapone—COMT—Metabolism—UGT1A1—lung cancer	0.000173	0.000804	CbGpPWpGaD
Entacapone—Pain—Etoposide—lung cancer	0.000172	0.000371	CcSEcCtD
Entacapone—Constipation—Etoposide—lung cancer	0.000172	0.000371	CcSEcCtD
Entacapone—Dysuria—Doxorubicin—lung cancer	0.000172	0.00037	CcSEcCtD
Entacapone—Decreased appetite—Paclitaxel—lung cancer	0.000171	0.00037	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CKB—lung cancer	0.000171	0.000794	CbGpPWpGaD
Entacapone—Dry mouth—Docetaxel—lung cancer	0.000171	0.000368	CcSEcCtD
Entacapone—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000171	0.000368	CcSEcCtD
Entacapone—Haemoglobin—Methotrexate—lung cancer	0.00017	0.000367	CcSEcCtD
Entacapone—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00017	0.000367	CcSEcCtD
Entacapone—Fatigue—Paclitaxel—lung cancer	0.00017	0.000367	CcSEcCtD
Entacapone—Haemorrhage—Methotrexate—lung cancer	0.00017	0.000366	CcSEcCtD
Entacapone—Hepatitis—Methotrexate—lung cancer	0.00017	0.000366	CcSEcCtD
Entacapone—Pollakiuria—Doxorubicin—lung cancer	0.00017	0.000365	CcSEcCtD
Entacapone—Asthenia—Gemcitabine—lung cancer	0.000169	0.000364	CcSEcCtD
Entacapone—Pain—Paclitaxel—lung cancer	0.000169	0.000364	CcSEcCtD
Entacapone—Constipation—Paclitaxel—lung cancer	0.000169	0.000364	CcSEcCtD
Entacapone—Confusional state—Docetaxel—lung cancer	0.000169	0.000363	CcSEcCtD
Entacapone—Pharyngitis—Methotrexate—lung cancer	0.000168	0.000363	CcSEcCtD
Entacapone—Urinary tract disorder—Methotrexate—lung cancer	0.000168	0.000361	CcSEcCtD
Entacapone—Oedema—Docetaxel—lung cancer	0.000167	0.00036	CcSEcCtD
Entacapone—Weight increased—Doxorubicin—lung cancer	0.000167	0.00036	CcSEcCtD
Entacapone—COMT—Metabolism—GNG11—lung cancer	0.000167	0.000775	CbGpPWpGaD
Entacapone—Pruritus—Gemcitabine—lung cancer	0.000167	0.000359	CcSEcCtD
Entacapone—Urethral disorder—Methotrexate—lung cancer	0.000166	0.000358	CcSEcCtD
Entacapone—Weight decreased—Doxorubicin—lung cancer	0.000166	0.000358	CcSEcCtD
Entacapone—Feeling abnormal—Etoposide—lung cancer	0.000166	0.000357	CcSEcCtD
Entacapone—Hyperglycaemia—Doxorubicin—lung cancer	0.000166	0.000357	CcSEcCtD
Entacapone—Diarrhoea—Irinotecan—lung cancer	0.000165	0.000357	CcSEcCtD
Entacapone—Pneumonia—Doxorubicin—lung cancer	0.000165	0.000355	CcSEcCtD
Entacapone—Gastrointestinal pain—Etoposide—lung cancer	0.000165	0.000355	CcSEcCtD
Entacapone—Shock—Docetaxel—lung cancer	0.000165	0.000355	CcSEcCtD
Entacapone—Nervous system disorder—Docetaxel—lung cancer	0.000164	0.000353	CcSEcCtD
Entacapone—Thrombocytopenia—Docetaxel—lung cancer	0.000164	0.000353	CcSEcCtD
Entacapone—Visual impairment—Methotrexate—lung cancer	0.000163	0.000352	CcSEcCtD
Entacapone—Feeling abnormal—Paclitaxel—lung cancer	0.000163	0.00035	CcSEcCtD
Entacapone—Skin disorder—Docetaxel—lung cancer	0.000162	0.00035	CcSEcCtD
Entacapone—Hypersensitivity—Cisplatin—lung cancer	0.000162	0.000349	CcSEcCtD
Entacapone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000161	0.000348	CcSEcCtD
Entacapone—Diarrhoea—Gemcitabine—lung cancer	0.000161	0.000347	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GSTM2—lung cancer	0.000161	0.000747	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CNDP2—lung cancer	0.000161	0.000747	CbGpPWpGaD
Entacapone—Erythema multiforme—Methotrexate—lung cancer	0.00016	0.000346	CcSEcCtD
Entacapone—Neuropathy peripheral—Doxorubicin—lung cancer	0.00016	0.000346	CcSEcCtD
Entacapone—Dizziness—Irinotecan—lung cancer	0.00016	0.000345	CcSEcCtD
Entacapone—Urticaria—Etoposide—lung cancer	0.00016	0.000344	CcSEcCtD
Entacapone—Anorexia—Docetaxel—lung cancer	0.000159	0.000344	CcSEcCtD
Entacapone—Body temperature increased—Etoposide—lung cancer	0.000159	0.000343	CcSEcCtD
Entacapone—Abdominal pain—Etoposide—lung cancer	0.000159	0.000343	CcSEcCtD
Entacapone—Urinary tract infection—Doxorubicin—lung cancer	0.000159	0.000343	CcSEcCtD
Entacapone—Conjunctivitis—Doxorubicin—lung cancer	0.000159	0.000343	CcSEcCtD
Entacapone—COMT—Metabolism—ALDOA—lung cancer	0.000159	0.000738	CbGpPWpGaD
Entacapone—Eye disorder—Methotrexate—lung cancer	0.000159	0.000342	CcSEcCtD
Entacapone—Asthenia—Cisplatin—lung cancer	0.000158	0.00034	CcSEcCtD
Entacapone—Cardiac disorder—Methotrexate—lung cancer	0.000157	0.000339	CcSEcCtD
Entacapone—Sweating—Doxorubicin—lung cancer	0.000157	0.000338	CcSEcCtD
Entacapone—Urticaria—Paclitaxel—lung cancer	0.000157	0.000338	CcSEcCtD
Entacapone—UGT1A9—Metabolism—MTMR3—lung cancer	0.000157	0.000727	CbGpPWpGaD
Entacapone—Hypotension—Docetaxel—lung cancer	0.000156	0.000337	CcSEcCtD
Entacapone—Haematuria—Doxorubicin—lung cancer	0.000156	0.000336	CcSEcCtD
Entacapone—Abdominal pain—Paclitaxel—lung cancer	0.000156	0.000336	CcSEcCtD
Entacapone—Body temperature increased—Paclitaxel—lung cancer	0.000156	0.000336	CcSEcCtD
Entacapone—Hepatobiliary disease—Doxorubicin—lung cancer	0.000155	0.000334	CcSEcCtD
Entacapone—Epistaxis—Doxorubicin—lung cancer	0.000154	0.000333	CcSEcCtD
Entacapone—COMT—Metabolism—NCOA3—lung cancer	0.000154	0.000716	CbGpPWpGaD
Entacapone—Vomiting—Irinotecan—lung cancer	0.000154	0.000331	CcSEcCtD
Entacapone—Sinusitis—Doxorubicin—lung cancer	0.000154	0.000331	CcSEcCtD
Entacapone—Agranulocytosis—Doxorubicin—lung cancer	0.000153	0.000329	CcSEcCtD
Entacapone—UGT1A9—Metabolism—PGAM1—lung cancer	0.000153	0.000708	CbGpPWpGaD
Entacapone—Rash—Irinotecan—lung cancer	0.000153	0.000329	CcSEcCtD
Entacapone—Dermatitis—Irinotecan—lung cancer	0.000152	0.000328	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000152	0.000328	CcSEcCtD
Entacapone—Headache—Irinotecan—lung cancer	0.000152	0.000327	CcSEcCtD
Entacapone—Insomnia—Docetaxel—lung cancer	0.000151	0.000326	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—HRAS—lung cancer	0.000151	0.000702	CbGpPWpGaD
Entacapone—Diarrhoea—Cisplatin—lung cancer	0.00015	0.000324	CcSEcCtD
Entacapone—Paraesthesia—Docetaxel—lung cancer	0.00015	0.000324	CcSEcCtD
Entacapone—COMT—Metabolism—ADCY1—lung cancer	0.00015	0.000697	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCG2—lung cancer	0.00015	0.000697	CbGpPWpGaD
Entacapone—Alopecia—Methotrexate—lung cancer	0.00015	0.000323	CcSEcCtD
Entacapone—Vomiting—Gemcitabine—lung cancer	0.00015	0.000323	CcSEcCtD
Entacapone—Bradycardia—Doxorubicin—lung cancer	0.00015	0.000322	CcSEcCtD
Entacapone—Dyspnoea—Docetaxel—lung cancer	0.000149	0.000321	CcSEcCtD
Entacapone—Somnolence—Docetaxel—lung cancer	0.000149	0.00032	CcSEcCtD
Entacapone—Mental disorder—Methotrexate—lung cancer	0.000149	0.00032	CcSEcCtD
Entacapone—Rash—Gemcitabine—lung cancer	0.000149	0.00032	CcSEcCtD
Entacapone—Dermatitis—Gemcitabine—lung cancer	0.000148	0.00032	CcSEcCtD
Entacapone—Hypersensitivity—Etoposide—lung cancer	0.000148	0.000319	CcSEcCtD
Entacapone—Malnutrition—Methotrexate—lung cancer	0.000148	0.000318	CcSEcCtD
Entacapone—Haemoglobin—Doxorubicin—lung cancer	0.000148	0.000318	CcSEcCtD
Entacapone—Headache—Gemcitabine—lung cancer	0.000148	0.000318	CcSEcCtD
Entacapone—Dyspepsia—Docetaxel—lung cancer	0.000147	0.000317	CcSEcCtD
Entacapone—COMT—Metabolism—ENO2—lung cancer	0.000147	0.000683	CbGpPWpGaD
Entacapone—COMT—Metabolism—HPGDS—lung cancer	0.000147	0.000683	CbGpPWpGaD
Entacapone—Hepatitis—Doxorubicin—lung cancer	0.000147	0.000317	CcSEcCtD
Entacapone—Haemorrhage—Doxorubicin—lung cancer	0.000147	0.000317	CcSEcCtD
Entacapone—COMT—Metabolism—PPP2R1B—lung cancer	0.000146	0.000679	CbGpPWpGaD
Entacapone—Hypoaesthesia—Doxorubicin—lung cancer	0.000146	0.000315	CcSEcCtD
Entacapone—Pharyngitis—Doxorubicin—lung cancer	0.000146	0.000314	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CYP2A7—lung cancer	0.000146	0.000676	CbGpPWpGaD
Entacapone—Decreased appetite—Docetaxel—lung cancer	0.000145	0.000313	CcSEcCtD
Entacapone—Hypersensitivity—Paclitaxel—lung cancer	0.000145	0.000313	CcSEcCtD
Entacapone—Urinary tract disorder—Doxorubicin—lung cancer	0.000145	0.000313	CcSEcCtD
Entacapone—Dysgeusia—Methotrexate—lung cancer	0.000145	0.000312	CcSEcCtD
Entacapone—Gastrointestinal disorder—Docetaxel—lung cancer	0.000144	0.000311	CcSEcCtD
Entacapone—Asthenia—Etoposide—lung cancer	0.000144	0.000311	CcSEcCtD
Entacapone—Fatigue—Docetaxel—lung cancer	0.000144	0.000311	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—lung cancer	0.000144	0.000669	CbGpPWpGaD
Entacapone—Urethral disorder—Doxorubicin—lung cancer	0.000144	0.00031	CcSEcCtD
Entacapone—Nausea—Irinotecan—lung cancer	0.000144	0.00031	CcSEcCtD
Entacapone—Constipation—Docetaxel—lung cancer	0.000143	0.000308	CcSEcCtD
Entacapone—Pain—Docetaxel—lung cancer	0.000143	0.000308	CcSEcCtD
Entacapone—Back pain—Methotrexate—lung cancer	0.000143	0.000308	CcSEcCtD
Entacapone—COMT—Metabolism—GSTT1—lung cancer	0.000143	0.000663	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SDC4—lung cancer	0.000142	0.000661	CbGpPWpGaD
Entacapone—Pruritus—Etoposide—lung cancer	0.000142	0.000307	CcSEcCtD
Entacapone—Visual impairment—Doxorubicin—lung cancer	0.000142	0.000305	CcSEcCtD
Entacapone—Asthenia—Paclitaxel—lung cancer	0.000142	0.000305	CcSEcCtD
Entacapone—COMT—Metabolism—CYP2A6—lung cancer	0.000141	0.000655	CbGpPWpGaD
Entacapone—COMT—Metabolism—GCLC—lung cancer	0.000141	0.000655	CbGpPWpGaD
Entacapone—Nausea—Gemcitabine—lung cancer	0.00014	0.000302	CcSEcCtD
Entacapone—Vomiting—Cisplatin—lung cancer	0.00014	0.000301	CcSEcCtD
Entacapone—Pruritus—Paclitaxel—lung cancer	0.00014	0.000301	CcSEcCtD
Entacapone—Vision blurred—Methotrexate—lung cancer	0.000139	0.0003	CcSEcCtD
Entacapone—Erythema multiforme—Doxorubicin—lung cancer	0.000139	0.000299	CcSEcCtD
Entacapone—Rash—Cisplatin—lung cancer	0.000138	0.000298	CcSEcCtD
Entacapone—Dermatitis—Cisplatin—lung cancer	0.000138	0.000298	CcSEcCtD
Entacapone—Feeling abnormal—Docetaxel—lung cancer	0.000138	0.000297	CcSEcCtD
Entacapone—Diarrhoea—Etoposide—lung cancer	0.000138	0.000297	CcSEcCtD
Entacapone—Eye disorder—Doxorubicin—lung cancer	0.000137	0.000296	CcSEcCtD
Entacapone—Ill-defined disorder—Methotrexate—lung cancer	0.000137	0.000295	CcSEcCtD
Entacapone—Gastrointestinal pain—Docetaxel—lung cancer	0.000137	0.000295	CcSEcCtD
Entacapone—Cardiac disorder—Doxorubicin—lung cancer	0.000136	0.000294	CcSEcCtD
Entacapone—Flushing—Doxorubicin—lung cancer	0.000136	0.000294	CcSEcCtD
Entacapone—Diarrhoea—Paclitaxel—lung cancer	0.000135	0.000291	CcSEcCtD
Entacapone—COMT—Metabolism—ENO1—lung cancer	0.000134	0.000621	CbGpPWpGaD
Entacapone—Malaise—Methotrexate—lung cancer	0.000133	0.000287	CcSEcCtD
Entacapone—Dizziness—Etoposide—lung cancer	0.000133	0.000287	CcSEcCtD
Entacapone—Vertigo—Methotrexate—lung cancer	0.000133	0.000286	CcSEcCtD
Entacapone—Abdominal pain—Docetaxel—lung cancer	0.000132	0.000285	CcSEcCtD
Entacapone—Body temperature increased—Docetaxel—lung cancer	0.000132	0.000285	CcSEcCtD
Entacapone—Leukopenia—Methotrexate—lung cancer	0.000132	0.000285	CcSEcCtD
Entacapone—Dizziness—Paclitaxel—lung cancer	0.00013	0.000281	CcSEcCtD
Entacapone—Nausea—Cisplatin—lung cancer	0.00013	0.000281	CcSEcCtD
Entacapone—Alopecia—Doxorubicin—lung cancer	0.00013	0.00028	CcSEcCtD
Entacapone—UGT1A9—Metabolism—RRM1—lung cancer	0.00013	0.000602	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTA3—lung cancer	0.00013	0.000602	CbGpPWpGaD
Entacapone—Cough—Methotrexate—lung cancer	0.000129	0.000278	CcSEcCtD
Entacapone—Mental disorder—Doxorubicin—lung cancer	0.000129	0.000277	CcSEcCtD
Entacapone—Convulsion—Methotrexate—lung cancer	0.000128	0.000276	CcSEcCtD
Entacapone—Vomiting—Etoposide—lung cancer	0.000128	0.000276	CcSEcCtD
Entacapone—Malnutrition—Doxorubicin—lung cancer	0.000128	0.000276	CcSEcCtD
Entacapone—Rash—Etoposide—lung cancer	0.000127	0.000273	CcSEcCtD
Entacapone—Dermatitis—Etoposide—lung cancer	0.000127	0.000273	CcSEcCtD
Entacapone—Headache—Etoposide—lung cancer	0.000126	0.000272	CcSEcCtD
Entacapone—Flatulence—Doxorubicin—lung cancer	0.000126	0.000272	CcSEcCtD
Entacapone—Chest pain—Methotrexate—lung cancer	0.000126	0.000271	CcSEcCtD
Entacapone—Myalgia—Methotrexate—lung cancer	0.000126	0.000271	CcSEcCtD
Entacapone—Tension—Doxorubicin—lung cancer	0.000125	0.00027	CcSEcCtD
Entacapone—Vomiting—Paclitaxel—lung cancer	0.000125	0.00027	CcSEcCtD
Entacapone—Dysgeusia—Doxorubicin—lung cancer	0.000125	0.00027	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000125	0.000269	CcSEcCtD
Entacapone—Rash—Paclitaxel—lung cancer	0.000124	0.000268	CcSEcCtD
Entacapone—Dermatitis—Paclitaxel—lung cancer	0.000124	0.000268	CcSEcCtD
Entacapone—Discomfort—Methotrexate—lung cancer	0.000124	0.000268	CcSEcCtD
Entacapone—Nervousness—Doxorubicin—lung cancer	0.000124	0.000268	CcSEcCtD
Entacapone—Back pain—Doxorubicin—lung cancer	0.000124	0.000267	CcSEcCtD
Entacapone—Headache—Paclitaxel—lung cancer	0.000124	0.000266	CcSEcCtD
Entacapone—Hypersensitivity—Docetaxel—lung cancer	0.000123	0.000266	CcSEcCtD
Entacapone—Muscle spasms—Doxorubicin—lung cancer	0.000123	0.000265	CcSEcCtD
Entacapone—UGT1A9—Metabolism—B4GALT5—lung cancer	0.000122	0.000566	CbGpPWpGaD
Entacapone—Confusional state—Methotrexate—lung cancer	0.000122	0.000262	CcSEcCtD
Entacapone—Vision blurred—Doxorubicin—lung cancer	0.000121	0.00026	CcSEcCtD
Entacapone—Asthenia—Docetaxel—lung cancer	0.00012	0.000259	CcSEcCtD
Entacapone—COMT—Metabolism—CYP2E1—lung cancer	0.00012	0.000557	CbGpPWpGaD
Entacapone—Nausea—Etoposide—lung cancer	0.00012	0.000258	CcSEcCtD
Entacapone—Ill-defined disorder—Doxorubicin—lung cancer	0.000119	0.000256	CcSEcCtD
Entacapone—COMT—Metabolism—NQO1—lung cancer	0.000119	0.000551	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTA4—lung cancer	0.000119	0.000551	CbGpPWpGaD
Entacapone—Pruritus—Docetaxel—lung cancer	0.000118	0.000255	CcSEcCtD
Entacapone—Nervous system disorder—Methotrexate—lung cancer	0.000118	0.000255	CcSEcCtD
Entacapone—Thrombocytopenia—Methotrexate—lung cancer	0.000118	0.000254	CcSEcCtD
Entacapone—Agitation—Doxorubicin—lung cancer	0.000118	0.000253	CcSEcCtD
Entacapone—Nausea—Paclitaxel—lung cancer	0.000117	0.000253	CcSEcCtD
Entacapone—Skin disorder—Methotrexate—lung cancer	0.000117	0.000252	CcSEcCtD
Entacapone—Hyperhidrosis—Methotrexate—lung cancer	0.000117	0.000251	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000116	0.000538	CbGpPWpGaD
Entacapone—COMT—Neuronal System—HRAS—lung cancer	0.000116	0.000538	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTA2—lung cancer	0.000116	0.000537	CbGpPWpGaD
Entacapone—Malaise—Doxorubicin—lung cancer	0.000115	0.000249	CcSEcCtD
Entacapone—Vertigo—Doxorubicin—lung cancer	0.000115	0.000248	CcSEcCtD
Entacapone—Anorexia—Methotrexate—lung cancer	0.000115	0.000248	CcSEcCtD
Entacapone—Syncope—Doxorubicin—lung cancer	0.000115	0.000247	CcSEcCtD
Entacapone—Leukopenia—Doxorubicin—lung cancer	0.000114	0.000247	CcSEcCtD
Entacapone—Diarrhoea—Docetaxel—lung cancer	0.000114	0.000247	CcSEcCtD
Entacapone—Palpitations—Doxorubicin—lung cancer	0.000113	0.000244	CcSEcCtD
Entacapone—Hypotension—Methotrexate—lung cancer	0.000113	0.000243	CcSEcCtD
Entacapone—Loss of consciousness—Doxorubicin—lung cancer	0.000112	0.000242	CcSEcCtD
Entacapone—Cough—Doxorubicin—lung cancer	0.000112	0.00024	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GSTA1—lung cancer	0.000112	0.000518	CbGpPWpGaD
Entacapone—Convulsion—Doxorubicin—lung cancer	0.000111	0.000239	CcSEcCtD
Entacapone—Dizziness—Docetaxel—lung cancer	0.000111	0.000238	CcSEcCtD
Entacapone—Hypertension—Doxorubicin—lung cancer	0.00011	0.000238	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ABCC3—lung cancer	0.00011	0.000512	CbGpPWpGaD
Entacapone—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00011	0.000237	CcSEcCtD
Entacapone—Insomnia—Methotrexate—lung cancer	0.000109	0.000235	CcSEcCtD
Entacapone—Chest pain—Doxorubicin—lung cancer	0.000109	0.000235	CcSEcCtD
Entacapone—Myalgia—Doxorubicin—lung cancer	0.000109	0.000235	CcSEcCtD
Entacapone—Anxiety—Doxorubicin—lung cancer	0.000108	0.000234	CcSEcCtD
Entacapone—Paraesthesia—Methotrexate—lung cancer	0.000108	0.000233	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000108	0.000233	CcSEcCtD
Entacapone—Discomfort—Doxorubicin—lung cancer	0.000108	0.000232	CcSEcCtD
Entacapone—Dyspnoea—Methotrexate—lung cancer	0.000107	0.000232	CcSEcCtD
Entacapone—Somnolence—Methotrexate—lung cancer	0.000107	0.000231	CcSEcCtD
Entacapone—COMT—Metabolism—STK11—lung cancer	0.000107	0.000496	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AKR1C1—lung cancer	0.000107	0.000496	CbGpPWpGaD
Entacapone—Dry mouth—Doxorubicin—lung cancer	0.000106	0.000229	CcSEcCtD
Entacapone—Vomiting—Docetaxel—lung cancer	0.000106	0.000229	CcSEcCtD
Entacapone—Dyspepsia—Methotrexate—lung cancer	0.000106	0.000229	CcSEcCtD
Entacapone—Rash—Docetaxel—lung cancer	0.000105	0.000227	CcSEcCtD
Entacapone—Dermatitis—Docetaxel—lung cancer	0.000105	0.000227	CcSEcCtD
Entacapone—Confusional state—Doxorubicin—lung cancer	0.000105	0.000227	CcSEcCtD
Entacapone—Decreased appetite—Methotrexate—lung cancer	0.000105	0.000226	CcSEcCtD
Entacapone—Headache—Docetaxel—lung cancer	0.000105	0.000226	CcSEcCtD
Entacapone—Oedema—Doxorubicin—lung cancer	0.000104	0.000225	CcSEcCtD
Entacapone—Gastrointestinal disorder—Methotrexate—lung cancer	0.000104	0.000224	CcSEcCtD
Entacapone—Fatigue—Methotrexate—lung cancer	0.000104	0.000224	CcSEcCtD
Entacapone—UGT1A9—Metabolism—UGT1A1—lung cancer	0.000104	0.000481	CbGpPWpGaD
Entacapone—Pain—Methotrexate—lung cancer	0.000103	0.000222	CcSEcCtD
Entacapone—Shock—Doxorubicin—lung cancer	0.000103	0.000221	CcSEcCtD
Entacapone—Nervous system disorder—Doxorubicin—lung cancer	0.000102	0.000221	CcSEcCtD
Entacapone—Thrombocytopenia—Doxorubicin—lung cancer	0.000102	0.00022	CcSEcCtD
Entacapone—Skin disorder—Doxorubicin—lung cancer	0.000101	0.000218	CcSEcCtD
Entacapone—Hyperhidrosis—Doxorubicin—lung cancer	0.000101	0.000217	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GNG11—lung cancer	0.0001	0.000464	CbGpPWpGaD
Entacapone—Anorexia—Doxorubicin—lung cancer	9.95e-05	0.000214	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.95e-05	0.000462	CbGpPWpGaD
Entacapone—Nausea—Docetaxel—lung cancer	9.93e-05	0.000214	CcSEcCtD
Entacapone—Feeling abnormal—Methotrexate—lung cancer	9.93e-05	0.000214	CcSEcCtD
Entacapone—COMT—Metabolism—GSTP1—lung cancer	9.89e-05	0.000459	CbGpPWpGaD
Entacapone—Gastrointestinal pain—Methotrexate—lung cancer	9.85e-05	0.000212	CcSEcCtD
Entacapone—Hypotension—Doxorubicin—lung cancer	9.75e-05	0.00021	CcSEcCtD
Entacapone—COMT—Metabolism—CAT—lung cancer	9.63e-05	0.000447	CbGpPWpGaD
Entacapone—Urticaria—Methotrexate—lung cancer	9.57e-05	0.000206	CcSEcCtD
Entacapone—Abdominal pain—Methotrexate—lung cancer	9.53e-05	0.000205	CcSEcCtD
Entacapone—Body temperature increased—Methotrexate—lung cancer	9.53e-05	0.000205	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ALDOA—lung cancer	9.52e-05	0.000442	CbGpPWpGaD
Entacapone—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.51e-05	0.000205	CcSEcCtD
Entacapone—Insomnia—Doxorubicin—lung cancer	9.44e-05	0.000203	CcSEcCtD
Entacapone—Paraesthesia—Doxorubicin—lung cancer	9.37e-05	0.000202	CcSEcCtD
Entacapone—COMT—Metabolism—ABCB1—lung cancer	9.36e-05	0.000435	CbGpPWpGaD
Entacapone—Dyspnoea—Doxorubicin—lung cancer	9.3e-05	0.000201	CcSEcCtD
Entacapone—Somnolence—Doxorubicin—lung cancer	9.28e-05	0.0002	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NCOA3—lung cancer	9.24e-05	0.000429	CbGpPWpGaD
Entacapone—COMT—Metabolism—TYMS—lung cancer	9.2e-05	0.000427	CbGpPWpGaD
Entacapone—Dyspepsia—Doxorubicin—lung cancer	9.19e-05	0.000198	CcSEcCtD
Entacapone—COMT—Metabolism—GSTM1—lung cancer	9.09e-05	0.000422	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.08e-05	0.000422	CbGpPWpGaD
Entacapone—Decreased appetite—Doxorubicin—lung cancer	9.07e-05	0.000196	CcSEcCtD
Entacapone—Gastrointestinal disorder—Doxorubicin—lung cancer	9.01e-05	0.000194	CcSEcCtD
Entacapone—Fatigue—Doxorubicin—lung cancer	9e-05	0.000194	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ADCY1—lung cancer	8.99e-05	0.000417	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCG2—lung cancer	8.99e-05	0.000417	CbGpPWpGaD
Entacapone—Constipation—Doxorubicin—lung cancer	8.92e-05	0.000192	CcSEcCtD
Entacapone—Pain—Doxorubicin—lung cancer	8.92e-05	0.000192	CcSEcCtD
Entacapone—Hypersensitivity—Methotrexate—lung cancer	8.88e-05	0.000191	CcSEcCtD
Entacapone—UGT1A9—Metabolism—HPGDS—lung cancer	8.82e-05	0.000409	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ENO2—lung cancer	8.82e-05	0.000409	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPP2R1B—lung cancer	8.76e-05	0.000407	CbGpPWpGaD
Entacapone—Asthenia—Methotrexate—lung cancer	8.65e-05	0.000186	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.64e-05	0.000401	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP1A1—lung cancer	8.62e-05	0.0004	CbGpPWpGaD
Entacapone—Feeling abnormal—Doxorubicin—lung cancer	8.6e-05	0.000185	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GSTT1—lung cancer	8.55e-05	0.000397	CbGpPWpGaD
Entacapone—COMT—Metabolism—ERCC2—lung cancer	8.55e-05	0.000397	CbGpPWpGaD
Entacapone—Gastrointestinal pain—Doxorubicin—lung cancer	8.53e-05	0.000184	CcSEcCtD
Entacapone—Pruritus—Methotrexate—lung cancer	8.53e-05	0.000184	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GCLC—lung cancer	8.45e-05	0.000392	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP2A6—lung cancer	8.45e-05	0.000392	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.42e-05	0.000391	CbGpPWpGaD
Entacapone—Urticaria—Doxorubicin—lung cancer	8.29e-05	0.000179	CcSEcCtD
Entacapone—Abdominal pain—Doxorubicin—lung cancer	8.25e-05	0.000178	CcSEcCtD
Entacapone—Body temperature increased—Doxorubicin—lung cancer	8.25e-05	0.000178	CcSEcCtD
Entacapone—Diarrhoea—Methotrexate—lung cancer	8.25e-05	0.000178	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ENO1—lung cancer	8.01e-05	0.000372	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.98e-05	0.000371	CbGpPWpGaD
Entacapone—Dizziness—Methotrexate—lung cancer	7.97e-05	0.000172	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.88e-05	0.000366	CbGpPWpGaD
Entacapone—Hypersensitivity—Doxorubicin—lung cancer	7.69e-05	0.000166	CcSEcCtD
Entacapone—Vomiting—Methotrexate—lung cancer	7.66e-05	0.000165	CcSEcCtD
Entacapone—Rash—Methotrexate—lung cancer	7.6e-05	0.000164	CcSEcCtD
Entacapone—Dermatitis—Methotrexate—lung cancer	7.59e-05	0.000164	CcSEcCtD
Entacapone—Headache—Methotrexate—lung cancer	7.55e-05	0.000163	CcSEcCtD
Entacapone—Asthenia—Doxorubicin—lung cancer	7.49e-05	0.000161	CcSEcCtD
Entacapone—COMT—Metabolism—APOA1—lung cancer	7.39e-05	0.000343	CbGpPWpGaD
Entacapone—Pruritus—Doxorubicin—lung cancer	7.38e-05	0.000159	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CYP2E1—lung cancer	7.19e-05	0.000334	CbGpPWpGaD
Entacapone—Nausea—Methotrexate—lung cancer	7.16e-05	0.000154	CcSEcCtD
Entacapone—Diarrhoea—Doxorubicin—lung cancer	7.14e-05	0.000154	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NQO1—lung cancer	7.11e-05	0.00033	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.96e-05	0.000323	CbGpPWpGaD
Entacapone—Dizziness—Doxorubicin—lung cancer	6.9e-05	0.000149	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.89e-05	0.00032	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CG—lung cancer	6.75e-05	0.000313	CbGpPWpGaD
Entacapone—Vomiting—Doxorubicin—lung cancer	6.63e-05	0.000143	CcSEcCtD
Entacapone—Rash—Doxorubicin—lung cancer	6.58e-05	0.000142	CcSEcCtD
Entacapone—Dermatitis—Doxorubicin—lung cancer	6.57e-05	0.000142	CcSEcCtD
Entacapone—Headache—Doxorubicin—lung cancer	6.54e-05	0.000141	CcSEcCtD
Entacapone—COMT—Metabolism—POMC—lung cancer	6.43e-05	0.000298	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—STK11—lung cancer	6.41e-05	0.000297	CbGpPWpGaD
Entacapone—COMT—Metabolism—CREBBP—lung cancer	6.26e-05	0.000291	CbGpPWpGaD
Entacapone—Nausea—Doxorubicin—lung cancer	6.2e-05	0.000134	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.01e-05	0.000279	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CD—lung cancer	5.93e-05	0.000276	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTP1—lung cancer	5.93e-05	0.000275	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALB—lung cancer	5.86e-05	0.000272	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CAT—lung cancer	5.77e-05	0.000268	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.73e-05	0.000266	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCB1—lung cancer	5.61e-05	0.00026	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—TYMS—lung cancer	5.51e-05	0.000256	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTM1—lung cancer	5.45e-05	0.000253	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CB—lung cancer	5.17e-05	0.00024	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP1A1—lung cancer	5.16e-05	0.00024	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS2—lung cancer	5.13e-05	0.000238	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ERCC2—lung cancer	5.12e-05	0.000238	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTEN—lung cancer	4.47e-05	0.000208	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOA1—lung cancer	4.43e-05	0.000206	CbGpPWpGaD
Entacapone—COMT—Metabolism—EP300—lung cancer	4.26e-05	0.000198	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.24e-05	0.000197	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CG—lung cancer	4.04e-05	0.000188	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—POMC—lung cancer	3.85e-05	0.000179	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CREBBP—lung cancer	3.75e-05	0.000174	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CD—lung cancer	3.56e-05	0.000165	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALB—lung cancer	3.51e-05	0.000163	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CA—lung cancer	3.15e-05	0.000146	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CB—lung cancer	3.1e-05	0.000144	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS2—lung cancer	3.07e-05	0.000143	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTEN—lung cancer	2.68e-05	0.000124	CbGpPWpGaD
Entacapone—COMT—Metabolism—AKT1—lung cancer	2.58e-05	0.00012	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—EP300—lung cancer	2.55e-05	0.000119	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CA—lung cancer	1.89e-05	8.77e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AKT1—lung cancer	1.54e-05	7.16e-05	CbGpPWpGaD
